In animal models of AD, increased tau phosphorylation has been observed in these layers compared to normal retinal tissues, in addition to microglial activation, loss of retinal ganglion cells (RGCs), and impaired retinal function. This evidence concerns the gene MAPT and Alzheimer disease.